Radient Technologies Inc
XTSX:RTI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Radient Technologies Inc
Research & Development
Radient Technologies Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Radient Technologies Inc
XTSX:RTI
|
Research & Development
-CA$349.1k
|
CAGR 3-Years
51%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$631m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$4.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Research & Development
-CA$27.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
|
Devonian Health Group Inc
XTSX:GSD
|
Research & Development
-CA$1.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Radient Technologies Inc
Glance View
Radient Technologies, Inc. engages in manufacture of natural ingredients in the food and beverage, nutrition and supplements, pharmaceuticals, and active care industries. The company is headquartered in Edmonton, Alberta. The company went IPO on 2011-08-24. The firm's principal activities are research, development and commercialization of technology for the extraction, isolation and purification of soluble products from a range of materials using microwave technology. The firm is focused on the formulation, manufacturing and launching of cannabis products. The company develops specialty products that contains a range of cannabinoid and terpene profiles. The company also operates a scientific and product testing laboratory that offers solutions to the cannabis and wellness spaces. Its extraction platform extracts cannabinoids from cannabis and hemp biomass. Its cannabis formulations include tinctures, topicals, sub-lingual sprays, standardized oils, stable water soluble and water dispersible powders and solid powders. Its cannabinoid-based ingredients are formulated for use in food and beverage products, personal care products and others.
See Also
What is Radient Technologies Inc's Research & Development?
Research & Development
-349.1k
CAD
Based on the financial report for Dec 31, 2022, Radient Technologies Inc's Research & Development amounts to -349.1k CAD.
What is Radient Technologies Inc's Research & Development growth rate?
Research & Development CAGR 5Y
16%
Over the last year, the Research & Development growth was -15%. The average annual Research & Development growth rates for Radient Technologies Inc have been 51% over the past three years , 16% over the past five years .
